Marc Labroli
Impact in
- Organic Chemistry top 5%
- Synthesis and Characterization of Pyrroles
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Multicomponent Synthesis of Heterocycles
- Catalytic C–H Functionalization Methods
- Virology top 5%
- HIV Research and Treatment
Papers in
-
- Cancer therapeutics and mechanisms 5
- DNA Repair Mechanisms 5
- Biochemical and Molecular Research 3
-
- Antimicrobial Resistance in Staphylococcus 4
- HIV/AIDS drug development and treatment 3
- Co-authors
- Qing Jin (3 shared papers)Dale L. Boger (3 shared papers)Christopher W. Boyce (1 shared paper)Clark A. Sehon (1 shared paper)Michael P. Dwyer (7 shared papers)Timothy J. Guzi (7 shared papers)Kamil Paruch (5 shared papers)Wolfgang Seghezzi (4 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (7 papers)Bioorganic & Medicinal Chemistry (3 papers)Tetrahedron Letters (2 papers)Journal of Medicinal Chemistry (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United States
In The Last Decade
Marc Labroli
19 papers receiving 923 citations
Peers
Comparison fields: 5 of 66
- Organic Chemistry 548
- Virology 85
- Pharmaceutical Science 36
- Oncology 161
- Molecular Biology 382
Countries citing papers authored by Marc Labroli
This map shows the geographic impact of Marc Labroli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Labroli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Labroli more than expected).
Fields of papers citing papers by Marc Labroli
This network shows the impact of papers produced by Marc Labroli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Labroli. The network helps show where Marc Labroli may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Labroli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 350 | |
| 2 | 2011 | 135 | |
| 3 | 2004 | 112 | |
| 4 | 2001 | 90 | |
| 5 | 2010 | 62 | |
| 6 | 2010 | 55 | |
| 7 | 2013 | 35 | |
| 8 | 2017 | 16 | |
| 9 | 2000 | 15 | |
| 10 | 2002 | 13 | |
| 11 | 2016 | 11 | |
| 12 | 1998 | 10 | |
| 13 | 2014 | 10 | |
| 14 | 2016 | 9 | |
| 15 | 1994 | 6 | |
| 16 | 2013 | 5 | |
| 17 | 2016 | 4 | |
| 18 | 2016 | 3 | |
| 19 | 2016 | 2 |
About Marc Labroli
Marc Labroli is a scholar working on Molecular Biology, Infectious Diseases, Organic Chemistry, Oncology and Molecular Medicine, having authored 19 papers that have together received 943 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), DNA Repair Mechanisms (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Antibiotic Resistance in Bacteria (3 papers), Cancer-related Molecular Pathways (3 papers), Biochemical and Molecular Research (3 papers), HIV/AIDS drug development and treatment (3 papers) and Microbial Natural Products and Biosynthesis (2 papers). The work is most often cited by research in Organic Chemistry (548 citations), Virology (85 citations), Pharmaceutical Science (36 citations), Oncology (161 citations) and Molecular Biology (382 citations). Marc Labroli has collaborated with scholars based in United States. Frequent co-authors include Qing Jin, Dale L. Boger, Christopher W. Boyce, Clark A. Sehon, Michael P. Dwyer, Timothy J. Guzi, Kamil Paruch, Wolfgang Seghezzi, David Parry and Nicole R. Davis. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry, Tetrahedron Letters, Journal of Medicinal Chemistry and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.